Literature DB >> 2834169

Effects of interleukin-1 and anti-inflammatory drugs on the degradation of human articular cartilage.

M Shinmei1, T Kikuchi, K Masuda, Y Shimomura.   

Abstract

It has been suggested that metalloproteases produced by chondrocytes play an important role in cartilage breakdown in joint diseases. The aim of this study was to investigate changes in enzyme activities in human rheumatoid and osteoarthritic articular cartilage. Cartilage fragments were incubated with various drugs for 48 hours. The concentrated culture media were used as enzyme solutions. Collagenase was assayed using FITC-collagen as the substrate. Proteoglycanase (PGase) was measured either by the release of 35S-labelled proteoglycans from cartilage into the medium, or by enzyme assay using proteoglycan monomer bound to fluorescein-conjugated hyaluronic acid as the substrate. Collagenase and proteoglycanase were found only in trace amounts in the concentrated media of healthy cartilage. Interleukin-1 (IL-1) enhanced the enzyme activities significantly. Marked increases of enzyme activities were observed in the concentrated media of rheumatoid (RA) and osteoarthritic (OA) cartilage. The sensitivity to interleukin-1 was also higher in OA and RA cartilage compared with healthy cartilage. Dexamethasone (10(-6) mol/L) markedly depressed enzyme activity. Tiaprofenic acid (4 x 10(-5) mol/L) also decreased enzyme activity, whereas indomethacin (4 x 10(-6) mol/L) and naproxen (3 x 10(-4) mol/L) had no effect.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2834169     DOI: 10.2165/00003495-198800351-00008

Source DB:  PubMed          Journal:  Drugs        ISSN: 0012-6667            Impact factor:   9.546


  14 in total

1.  Proteoglycan- and collagen-degrading enzymes from human interleukin 1-stimulated chondrocytes from several species: proteoglycanase and collagenase inhibitors as potentially new disease-modifying antiarthritic agents.

Authors:  G DiPasquale; R Caccese; R Pasternak; J Conaty; S Hubbs; K Perry
Journal:  Proc Soc Exp Biol Med       Date:  1986-11

2.  Extracts of human articular cartilage contain an inhibitor of tissue metalloproteinases.

Authors:  D D Dean; J F Woessner
Journal:  Biochem J       Date:  1984-02-15       Impact factor: 3.857

3.  An assay for proteoglycanase (PGase) and it's application to articular chondrocyte cultures.

Authors:  M Shinmei; K Miyazaki; T Kikuchi; Y Shimomura
Journal:  Agents Actions Suppl       Date:  1986

4.  In vitro activation of human chondrocytes and synoviocytes by a human interleukin-1-like factor.

Authors:  M B McGuire-Goldring; J E Meats; D D Wood; E J Ihrie; N M Ebsworth; R G Russell
Journal:  Arthritis Rheum       Date:  1984-06

5.  Two latent metalloproteases of human articular cartilage that digest proteoglycan.

Authors:  J F Woessner; M G Selzer
Journal:  J Biol Chem       Date:  1984-03-25       Impact factor: 5.157

6.  Neutral proteases capable of proteoglycan digesting activity in osteoarthritic and normal human articular cartilage.

Authors:  J Martel-Pelletier; J P Pelletier; J M Cloutier; D S Howell; L Ghandur-Mnaymneh; J F Woessner
Journal:  Arthritis Rheum       Date:  1984-03

7.  Effects of antirheumatoid drugs on the production and action of porcine catabolin.

Authors:  H Sheppeard; L M Pilsworth; B Hazleman; J T Dingle
Journal:  Ann Rheum Dis       Date:  1982-10       Impact factor: 19.103

8.  Human rheumatoid arthritic cartilage and its neutral proteoglycan-degrading proteases. The effects of antirheumatic drugs.

Authors:  J Martel-Pelletier; J M Cloutier; D S Howell; J P Pelletier
Journal:  Arthritis Rheum       Date:  1985-04

9.  Interleukin 1 induces leukocyte infiltration and cartilage proteoglycan degradation in the synovial joint.

Authors:  E R Pettipher; G A Higgs; B Henderson
Journal:  Proc Natl Acad Sci U S A       Date:  1986-11       Impact factor: 11.205

10.  Anti-rheumatic drugs and joint damage in rheumatoid arthritis.

Authors:  D L Scott; P T Dawes; P D Fowler; K A Grindulis; M Shadforth; P A Bacon
Journal:  Q J Med       Date:  1985-01
View more
  5 in total

1.  Study of the effect of a glycosaminoglycan-peptide complex on the degradative enzyme activities in human osteoarthritic cartilage.

Authors:  E Vignon; A Martin; P Mathieu; T Conrozier; P Louisot; M Richard
Journal:  Clin Rheumatol       Date:  1990-09       Impact factor: 2.980

Review 2.  Articular cartilage destruction in experimental inflammatory arthritis: insulin-like growth factor-1 regulation of proteoglycan metabolism in chondrocytes.

Authors:  P J Verschure; C J Van Noorden; J Van Marle; W B Van den Berg
Journal:  Histochem J       Date:  1996-12

Review 3.  'Chondroprotection' by non-steroidal anti-inflammatory drugs.

Authors:  M Doherty
Journal:  Ann Rheum Dis       Date:  1989-08       Impact factor: 19.103

4.  Effects of certain antiarthritic agents on the synthesis of type II collagen and glycosaminoglycans in rat chondrosarcoma cultures.

Authors:  G R Srinivas; C O Chichester; H J Barrach; A L Matoney
Journal:  Agents Actions       Date:  1994-05

5.  Inhibition of interleukin 1 beta induced rat and human cartilage degradation in vitro by the metalloproteinase inhibitor U27391.

Authors:  M P Seed; S Ismaiel; C Y Cheung; T A Thomson; C R Gardner; R M Atkins; C J Elson
Journal:  Ann Rheum Dis       Date:  1993-01       Impact factor: 19.103

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.